[article]
| Titre : |
Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home |
| Type de document : |
texte imprimé |
| Auteurs : |
Lisa M. RUIZ, Auteur ; Mackenzie DAMRON, Auteur ; Kyle B. JONES, Auteur ; Dean WEEDON, Auteur ; Paul S. CARBONE, Auteur ; Amanda V. BAKIAN, Auteur ; Deborah A. BILDER, Auteur |
| Article en page(s) : |
p.1887-1894 |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Antipsychotics Autism spectrum disorder Intellectual disability Medical home |
| Index. décimale : |
PER Périodiques |
| Résumé : |
This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4 %) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism spectrum disorder (p = 0.001 and p = 0.04, respectively), and inversely associated with the youngest and oldest age categories (p = 0.001 and p = 0.04, respectively). Among those taking antipsychotics, annual metabolic monitoring rates ranged from 89 % (lipids) to 99 % (weight). Age was positively associated with glucose (p < 0.001) and lipid monitoring (p < 0.001). Adult participants with dyslipidemia (p < 0.01), prediabetes/diabetes (p = 0.04), and hypertension (p = 0.02) were significantly more likely to obtain lipid monitoring. These values exceeded previously reported rates suggesting the importance of an integrated care model. |
| En ligne : |
http://dx.doi.org/10.1007/s10803-016-2712-x |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=288 |
in Journal of Autism and Developmental Disorders > 46-6 (June 2016) . - p.1887-1894
[article] Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home [texte imprimé] / Lisa M. RUIZ, Auteur ; Mackenzie DAMRON, Auteur ; Kyle B. JONES, Auteur ; Dean WEEDON, Auteur ; Paul S. CARBONE, Auteur ; Amanda V. BAKIAN, Auteur ; Deborah A. BILDER, Auteur . - p.1887-1894. Langues : Anglais ( eng) in Journal of Autism and Developmental Disorders > 46-6 (June 2016) . - p.1887-1894
| Mots-clés : |
Antipsychotics Autism spectrum disorder Intellectual disability Medical home |
| Index. décimale : |
PER Périodiques |
| Résumé : |
This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4 %) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism spectrum disorder (p = 0.001 and p = 0.04, respectively), and inversely associated with the youngest and oldest age categories (p = 0.001 and p = 0.04, respectively). Among those taking antipsychotics, annual metabolic monitoring rates ranged from 89 % (lipids) to 99 % (weight). Age was positively associated with glucose (p < 0.001) and lipid monitoring (p < 0.001). Adult participants with dyslipidemia (p < 0.01), prediabetes/diabetes (p = 0.04), and hypertension (p = 0.02) were significantly more likely to obtain lipid monitoring. These values exceeded previously reported rates suggesting the importance of an integrated care model. |
| En ligne : |
http://dx.doi.org/10.1007/s10803-016-2712-x |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=288 |
|  |
Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home in Journal of Autism and Developmental Disorders, 46-6 (June 2016)
